Mirogabalin for the treatment of diabetic peripheral neuropathic pain: A randomized, double‐blind, placebo‐controlled phase III study in Asian patients

AIMS/INTRODUCTION: This study evaluated the efficacy and safety of mirogabalin, a novel, potent, selective ligand of the α(2)δ subunit of voltage‐dependent Ca(2+) channels, for the treatment of diabetic peripheral neuropathic pain (DPNP). MATERIALS AND METHODS: During this double‐blind, multisite, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Baba, Masayuki, Matsui, Norimitsu, Kuroha, Masanori, Wasaki, Yosuke, Ohwada, Shoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717827/
https://www.ncbi.nlm.nih.gov/pubmed/30672128
http://dx.doi.org/10.1111/jdi.13013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717827/
https://www.ncbi.nlm.nih.gov/pubmed/30672128
http://dx.doi.org/10.1111/jdi.13013

Ejemplares similares